Amylyx Pharmaceuticals, Inc. AMLX
Set alert
28.86 USD +0.18 +0.63%
At close · Oct 30
28.86 0.00 0.00%
After hours · Oct 30, 4:33 PM ET
28.00 Day range 29.09
11.38 52-week range 39.66
- YTD
- +138.91%
- 1 year
- +105.41%
- Open
- 28.41
- Prev close
- 28.68
- Mkt cap
- 3.62B
- Vol
- 989.52K
- Avg vol
- 2.21M
- EPS
- -1.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.00
- High
- 29.09
- Forward P/E
- -26.47
- Beta
- -0.09
- Short ratio
- 9.49
- Inst. own
- 94.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 31.11
- 200-d avg
- 20.00
- 1y target
- 43.00
MAX chart
Events in this range
- Aug 7, 2025Earnings: -0.46; estimate -0.44; surprise -4.55%
- Nov 6, 2025Earnings: -0.37; estimate -0.43; surprise 13.95%
- Mar 3, 2026Earnings: -0.3; estimate -0.31; surprise 3.23%
- May 7, 2026Earnings: -0.37; estimate -0.34; surprise -8.82%
- Aug 6, 2026Earnings: -0.39; estimate -0.3609; surprise -8.06%
- Aug 18, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 19, 2026Rating: Baird · Outperform → Outperform
- Aug 19, 2026Rating: Guggenheim · Buy → Buy
- Aug 19, 2026Rating: Mizuho · Outperform → Outperform
- Aug 27, 2026Rating: Guggenheim · Buy → Buy
- Oct 15, 2026Rating: Citigroup · Buy → Buy
- Nov 5, 2026Earnings: —; estimate -0.38099; surprise —%
Signals (68)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 1, 2025 | 11 months ago |
| RSI: Overbought | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| RSI: Overbought | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 7, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Jul 1, 2024 | 2 years ago |
| SMA: Bullish | Jun 24, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 4, 2024 | 2 years ago |
| RSI: Oversold | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Dec 25, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 18, 2023 | 2 years ago |
| RSI: Oversold | Nov 6, 2023 | 2 years ago |
| RSI: Oversold | Oct 2, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 28, 2023 | 3 years ago |
| RSI: Oversold | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Feb 13, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 2, 2023 | 3 years ago |
| SMA: Bullish | Dec 26, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | May 30, 2022 | 4 years ago |
| SMA: Bearish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
| SMA: Bearish | Mar 14, 2022 | 4 years ago |
Financial health
Altman Z-Score
80.35 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -7.9×
FY 2019 5y median -7.9× FY 2025
P/S 0.0×
FY 2019 5y median 2.6× FY 2025
P/B 3.7×
FY 2019 5y median 2.3× FY 2025
P/FCF -9.3×
FY 2019 5y median -9.3× FY 2025
EV/EBITDA -6.4×
FY 2019 5y median -6.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 2.1× FY 2025
FCF Yield -10.8%
FY 2019 5y median -7.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 51.8% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -47.4%
FY 2019 5y median -47.4% FY 2025
ROIC -49.3%
FY 2019 5y median -58.0% FY 2025
ROA -43.5%
FY 2019 5y median -50.7% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2019 FY 2025
Operating Income 51.3%
FY 2019 FY 2025
EPS (diluted) 65.5%
FY 2019 FY 2025
Free Cash Flow 26.4%
FY 2019 FY 2025
Financial Health
Current Ratio 14.3×
FY 2019 5y median 6.7× FY 2025
Quick Ratio 14.3×
FY 2019 5y median 6.7× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.5×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31